Abstract
It has been estimated that 800 000 American males present annually with symptoms and signs of benign prostatic hyperplasia (BPH) requiring some therapy. Of these 800 000 patients, 400 000 are treated surgically each year (Rutkow 1986). The annual cost of treatment of BPH was estimated in the United States in 1990 to be approximately 4.0 billion dollars (Cotton 1991). In spite of a large number of patients being treated for BPH, the indications for the treatment are not well defined. It has been suggested that less than 25% of surgically treated patients have “solid“ indications for this treatment. Wide geographic variations in the incidence of prostatectomy have been reported. In an interesting study comparing the incidence of common surgical procedures between New England, Norway, and the West Midlands District of England, the incidence of prostatectomy per 100 000 population was 264, 236, and 132, respectively (McPherson et al. 1982). If the current incidence of prostatectomy does not change, nearly 30% of American males will have undergone this procedure by the age of 80 (Glynn et al. 1985).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Astrahan MA, Ameye F, Oyen R, et al. (1991) Interstitial temperature measurements during transurethral hyperthermia. J Urol 145:304–308
Baert L, Ameye F, Willemen P, et al. (1990) Transurethral microwave hyperthermia for benign prostatic hyperplasia: preliminary clinical results. J. Urol 144:1383–1387
Baert L, Willemen P, Ameye F, Petrovich Z (1991) Transurethral microwave hyperthermia: treatment response in different forms of benign prostatic hyperplasia. Prostate 18:315–320
Baert L, Ameye F, Pile M, et al. (1992) Transurethral hyperthermia for BPH patients with retention. J Urol 147:1558–1561
Baert L, Verhamme L, Van Poppel H, et al. (1993a) Long term consequences of urethral stents. Br J Urol 68:604–607
Baert L, Ameye F, Pike M, Petrovich Z (1993b) Optimization of transurethral hyperthermia: number of treatments. Urology (in press)
Barry MJ, Fowler FJ Jr, O’Leary MP, et al. (1992) The Measurement Committee of the American Urological Association’s Symptom Index for Benign Prostatic Hyperplasia. J Urol 148:1549–1557
Berg C, Choi N, Colombeau P, et al. (1993) Responders versus non-responders to thermotherapy in BPH: a multicenter retrospective analysis of patients and treatment profiles. J Urol (in press)
Blute ML, Tomera KM, Hellerstein DK, et al. (1992) Transurethral microwave thermotherapy for prostatism: early Mayo Foundation experience. Mayo Clin Proc 67:417–421
Bruskewitz RC, Larsen EH, Madsen PO, Dorflinger T (1986) 3 year follow-up of urinary symptoms after transurethral resection of the prostate. J Urol 136:613–615
Cotton P (1991) Case for prostate therapy wanes despite more treatment options. JAMA 266:459–460
Debicki P, Astrahan MA, Ameye F, et al. (1992) Temperature steering in prostate by simultaneous transurethral and transrectal hyperthermia. Urology 40:300–306
Devonec M, Berger N, Perrin P (1991) Transurethral microwave heating of the prostate: from hyperthermia to thermotherapy. J Endourol 5:129–135
Devonec M, Fendler JP, Jouver P, et al. (1993) Thermotherapy in benign prostatic hypertrophy: an update of clinical results and latest developments. J Endourol (in press)
Fowler FJ, Wennberg JE, Timothy RP, et al. (1988) Symptom status and quality of life following prostatectomy. JAMA 259:3018–3022
Glynn RJ, Campion EW, Bouchard GR, et al. (1985) The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 121:78–90
Gormley GJ, Stoner E, Bruskewitz RC, et al. and Finasteride Study Group (1992) The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 327:1185–1191
Graversen PH, Gasser TC, Wasson JH, et al. (1989) Controversies about indications for transurethral resection of the prostate. J Urol 141:475–481
Kabalin JN (1993) Laser prostatectomy performed with a right angle firing neodymium:Yag laser fiber at 40 watts power setting. J Urol 150:95–99
Kaplan SA, Shabsigh R, Soldo KA, Olsson CA (1992) Prostatic and periprostatic temperature measurements in patients treated with transrectal thermal therapy (local intracavitary microwave hyperthermia). J Urol 147:1562–1565
Lauweryns J, Baert L, Yandenhove J, Petrovich Z (1991) Histopathology of prostatic tissue after transurethral hyperthermia. Int J Hyperthermia 7:221–230
Lepor H, Rigaud G (1990) The efficacy of the transurethral resection of the prostate in men with moderate symptoms of prostatism. J Urol 143:533–537
Lepor H, Sypherd D, Machi G, Derus J (1992a) Randomized double-blind study comparing the effectiveness of balloon dilation of the prostatic hyperplasia. J Urol 147:639–644
Lepor H, Auerbach S, Puras-Baez A, et al. (1992b) A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol 148:1467–1474
Libman E, Fichten CS (1987) Prostatectomy and sexual function. Urology 29:467–478
Lindner A, Braf Z, Lev A, et al. (1990a) Local hyperthermia of the prostate gland for the treatment of benign prostatic hypertrophy and urinary retention. Br J Urol 65:201–203
Lindner A, Siegel YI, Sarange R, et al. (1990b) Complications in hyperthermia treatment of benign prostatic hyperplasia. J Urol 144:1390–1392
McPherson K, Wennberg JE, Hovind OB, Clifford P (1982) Small area variations in the use of common surgical procedures: an international comparison of New England, England and Norway. N Engl J Med 307:1310–1314
Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC and Writing Committee (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 141:243–246
Melchior J, Valk WL, Foret JD, Mebust WK (1974) Transurethral prostatectomy: computerized analysis of 2,223 consecutive cases. J Urol 112:634–642
Montorsi F, Galli L, Guazzoni G, et al. (1992) Transrectal microwave hyperthermia for benign prostatic hyperplasia: long term clinical, pathological and ultrastructural patterns. J Urol 148:321–325
Ogden CW, Reddy P, Johnson H, et al. (1993) Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet 341:14–17
Petrovich Z, Ameye F, Pike M, et al. (1992) Relationship of response to transurethral hyperthermia and prostate volume in BPH patients. Urology 40:317–321
Petrovich Z, Ameye F, Baert L, et al. (1993) New trends in the treatment of benign prostatic hyperplasia and carcinoma of the prostate. Am J Clin Oncol 16:187–200
Pettersson S, Dahlstrand C, Fall M, et al. (1992) Transurethral microwave thermotheraphy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomized study (abstract). J Urol 147A:305A
Roos NP, Ramsey EW (1987) A population based study of prostatectomy: outcomes associated with differing surgical approaches. J Urol 137:1184–1188
Roos NP, Wenneberg JE, Malenka DJ, et al. (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 32:1120–1124
Rutkow IM (1986) Urological operations in the United States: 1979–1984. J Urol 135:1206–1208
Sapozink MD, Boyd SD, Astrahan MA, et al. (1990) Transurethral hyperthermia for benign prostatic hyperplasia: preliminary clinical results. J Urol 143:944–950
Saranga R, Matzkin H, Braf Z (1990) Local microwave hyperthermia in the treatment of benign prostatic hypertrophy. Br J Urol 65:349–353
Stawarz B, Szmigielski S, Ogrodnik J, et al. (1991) A comparison of transurethral and transrectal microwave hyperthermia in poor surgical risk benign prostatic hyperplasia patients. J Urol 146:353–357
Strohmaier WL, Bichler KH, Fluchter SH, Wilbert DM (1990) Local microwave hyperthermia of benign prostatic hyperplasia. J Urol 144:913–917
Yerushalmi A, Fishelovitz Y, Singer D, et al. (1985) Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol 133:873–876
Zerbib M, Steg A, Conquy S, et al. (1992) Localized hyperthermia versus the sham procedure in obstructive benign hyperplasia of the prostate: a prospective randomized study. J Urol 147:1048–1052
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Petrovich, Z., Ameye, F., Baert, L. (1994). Optimization of Treatment for Benign Prostatic Hyperplasia: Outcome of Clinical Trails and Future Directions. In: Petrovich, Z., Baert, L. (eds) Benign Prostatic Hyperplasia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78185-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-78185-8_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78187-2
Online ISBN: 978-3-642-78185-8
eBook Packages: Springer Book Archive